Sort   by:  
 Page size 
MetabolomicsA multiomic approach to reveal gastrointestinal toxicity mechanisms associated with mycophenolate mofetil in neuromyelitis optica spectrum disorders
Mycophenolate mofetil (MMF) has been widely prescribed for neuromyelitis optica spectrum disorders (NMOSD) although some patients experience severe gastrointestinal (GI) side effects following MMF administration. Our study investigated the potential mechanisms of this toxicity in NMOSD patients. We ...
2024-06-18 | MTBLS4392 | MetaboLights
MetabolomicsTCA Concentrations in Neuromyelitis Optica Patients (part - II)
Not available
ORGANISM(S): Homo sapiens 
ST001036 | MetabolomicsWorkbench
MetabolomicsTCA Isotopomers in Neuromyelitis Optica Patients (part - I)
Not available
ORGANISM(S): Homo sapiens 
ST001035 | MetabolomicsWorkbench
ProteomicsHuman cerebrospinal fluid exosome, LC-MSMS
Quantitative proteomics analysis of exosomes isolated from cerebrospinal fluid of neuromyelitis optica patients detected potential distinctive disease markers capable of differentiating from multiple sclerosis and idiopathic longitudinally extensive transverse myelitis. Exosomes were enriched with ...
ORGANISM(S): Homo sapiens (Human) 
2016-09-27 | PXD002424 | Pride
Exosome Neuromyelitis optica Multiple sclerosis Cerebrospinal fluid 
ProteomicsDifferential serum proteomics of neuromyelitis spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are two types of autoimmune-mediated central nervous system (CNS) inflammatory demyelinating diseases that have similar clinical manifestations but with different pathogenesis a...
ORGANISM(S): Homo Sapiens 
2024-12-25 | PXD059225 |
UnknownA meta-analysis comparing first-line immunosuppressants in neuromyelitis optica.
Not available
S-EPMC8528466 | biostudies-literature
GenomicsATP mediates neuropathic pain of neuromyelitis optica spectrum disorder via microglial activation
ATP mediates neuropathic pain of neuromyelitis optica spectrum disorder via microglial activation
PRJNA632887 | ENA
GenomicsRare variants and HLA haplotypes associated in Serbian patients with Neuromyelitis Optica Spectrum Disorders
Rare variants and HLA haplotypes associated in Serbian patients with Neuromyelitis Optica Spectrum Disorders
PRJNA879241 | ENA
GenomicsRare variants and HLA haplotypes associated in Serbian patients with Neuromyelitis Optica Spectrum Disorders
Rare variants and HLA haplotypes associated in Serbian patients with Neuromyelitis Optica Spectrum Disorders
PRJNA879242 | ENA
UnknownUpdate on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Not available
S-EPMC10267280 | biostudies-literature
Sort   by:  
 Page size